Header cover image

U.S. Top Stock Picks from Analysts

Results

1289

0 new

Companies which are more than 50% undervalued based on analyst price target.

1,289 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
BDRX
Biodexa Pharmaceuticals		US$3.71-13.1%-90.0%US$2.2mUS$18.05PS20.6xS-97.7%n/aPharmaceuticals & Biotech
REVB
Revelation Biosciences		US$4.310.7%-90.4%US$1.7mUS$170.73PB0.7xS68.2%n/aPharmaceuticals & Biotech
SHWZ
Medicine Man Technologies		US$0.020%-98.5%US$1.6mUS$2.64PS0.009xS6.4%n/aPharmaceuticals & Biotech
TRVN
Trevena		US$1.67-7.7%-88.1%US$1.4mUS$5.00PS2.6xE46.2%n/aPharmaceuticals & Biotech
VRPX
Virpax Pharmaceuticals		US$0.26-19.5%-92.2%US$1.3mUS$3.00PE-0.1xE31.1%n/aPharmaceuticals & Biotech
SONX
Sonendo		US$2.9212.4%-91.9%US$1.2mUS$30.00PS0.03xE21.8%n/aHealthcare
CYN
Cyngn		US$7.76-44.0%-99.7%US$1.1mUS$1,799.99PS10.9xS214.0%n/aSoftware
SCPX
Scorpius Holdings		US$0.21-20.4%-99.6%US$1.0mUS$5.00PS0.1xE75.2%n/aPharmaceuticals & Biotech
NMHI
Nature's Miracle Holding		US$0.3910.0%-99.8%US$1.0mUS$21.00PS0.1xE65.5%n/aCapital Goods
TCBP
TC Biopharm (Holdings)		US$2.502.5%-98.5%US$1.0mUS$48.00PB0.4xE-10.1%n/aPharmaceuticals & Biotech
BPTH
Bio-Path Holdings		US$0.18-70.8%-96.8%US$796.8kUS$12.00PE-0.08xE58.3%n/aPharmaceuticals & Biotech
LFLY
Leafly Holdings		US$0.22-17.7%-93.9%US$659.9kUS$7.59PS0.02xS-2.4%n/aMedia
CYTO.F
Altamira Therapeutics		US$0.1330.0%-92.8%US$606.1kUS$5.29PB0.1xE-4.4%n/aPharmaceuticals & Biotech
BIOR.Q
Biora Therapeutics		US$0.12-2.0%-98.6%US$530.8kUS$34.00PS0.6xE-21.5%n/aPharmaceuticals & Biotech
LGMK
LogicMark		US$0.26-56.3%-98.9%US$523.7kUS$4.00PS0.05xn/an/aHealthcare
ZPTA
Zapata Computing Holdings		US$0.010%-99.9%US$386.3kUS$1.75PS0.06xE48.8%n/aSoftware
GMVD.F
G Medical Innovations Holdings		US$0.00019,900.0%-99.3%US$26.4kUS$210.00n/an/an/aHealthcare
Page 54 of 54